We've put some small files called cookies on your device to make our site work.
We'd also like to use analytics cookies. These send information about how our site is used to a service called Google Analytics. We use this information to improve our site.
Let us know if this is OK. We'll use a cookie to save your choice. You canĀ read more about our cookies before you choose.
Patient safety alert: Resources to support the safety of girls and women who are being treated with valproate
This resource alert has been issued jointly by NHS Improvement and the Medicines and Healthcare products Regulatory Agency (MHRA) to support the safety of girls and women of childbearing potential being treated with valproate.
MHRA have also produced a video for GPs, pharmacists and other healthcare professionals on the latest advice about the risk of valproate medicine during pregnancy and the contents of the valproate toolkit.